| Dr Lucase H Wang, MD | |
|
1300 E A St Ste 206, Casper, WY 82601-2252 | |
| (307) 265-2400 | |
| (307) 265-2566 |
| Full Name | Dr Lucase H Wang |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1300 E A St Ste 206, Casper, Wyoming |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316072788 | NPI | - | NPPES |
| 9928537 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | A91742 (California) | Secondary |
| 208000000X | Pediatrics | 7923A (Wyoming) | Primary |
| Entity Name | Lander Valley Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215971510 PECOS PAC ID: 5597657080 Enrollment ID: O20040329000810 |
News Archive
Genetic research on concussions is progressing in many different avenues. However, researchers presenting their work at the American Orthopaedic Society for Sports Medicine's Specialty Day, believe there may be a new genetic connection regarding recovery rates following a sports-related concussion.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.
A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.
In a study published in The American Journal of Gastroenterology, researchers found that budesonide capsules are an effective treatment to prolong and maintain the period of remission of Crohn's Disease. Previous studies have demonstrated that budesonide is effective for inducing remission of Crohn's disease.
› Verified 2 days ago
| Entity Name | Riverton Physician Practices, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205875614 PECOS PAC ID: 8426954496 Enrollment ID: O20040505000232 |
News Archive
Genetic research on concussions is progressing in many different avenues. However, researchers presenting their work at the American Orthopaedic Society for Sports Medicine's Specialty Day, believe there may be a new genetic connection regarding recovery rates following a sports-related concussion.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.
A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.
In a study published in The American Journal of Gastroenterology, researchers found that budesonide capsules are an effective treatment to prolong and maintain the period of remission of Crohn's Disease. Previous studies have demonstrated that budesonide is effective for inducing remission of Crohn's disease.
› Verified 2 days ago
| Entity Name | Ivinson Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033628599 PECOS PAC ID: 8325304447 Enrollment ID: O20171213002021 |
News Archive
Genetic research on concussions is progressing in many different avenues. However, researchers presenting their work at the American Orthopaedic Society for Sports Medicine's Specialty Day, believe there may be a new genetic connection regarding recovery rates following a sports-related concussion.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.
A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.
In a study published in The American Journal of Gastroenterology, researchers found that budesonide capsules are an effective treatment to prolong and maintain the period of remission of Crohn's Disease. Previous studies have demonstrated that budesonide is effective for inducing remission of Crohn's disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lucase H Wang, MD 1300 E A St Ste 206, Casper, WY 82601-2252 Ph: (307) 265-2400 | Dr Lucase H Wang, MD 1300 E A St Ste 206, Casper, WY 82601-2252 Ph: (307) 265-2400 |
News Archive
Genetic research on concussions is progressing in many different avenues. However, researchers presenting their work at the American Orthopaedic Society for Sports Medicine's Specialty Day, believe there may be a new genetic connection regarding recovery rates following a sports-related concussion.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.
A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.
In a study published in The American Journal of Gastroenterology, researchers found that budesonide capsules are an effective treatment to prolong and maintain the period of remission of Crohn's Disease. Previous studies have demonstrated that budesonide is effective for inducing remission of Crohn's disease.
› Verified 2 days ago
Diane R Edwards, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 915 S David, Casper, WY 82601 Phone: 307-472-3769 | |
Robert Anthony Vigneri, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 940 E 3rd St, Suite 203, Casper, WY 82601 Phone: 307-577-0465 Fax: 307-577-0469 | |
Dr. Ismaeel Mohamed Bakhsh, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1020 Conwell St., Casper, WY 82601 Phone: 516-808-1917 | |
Dr. Shelley C Springer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 940 E 3rd St Ste 205, Casper, WY 82601 Phone: 307-577-4260 Fax: 307-577-4263 | |
Dr. Melissa M. Knudson-johnson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 940 E 3rd St Ste 203, Casper, WY 82601 Phone: 307-333-6940 Fax: 888-964-2162 | |
Dr. Richard Dewar Green, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 940 E 3rd St, #102, Casper, WY 82601 Phone: 330-757-7428 |